|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oversikt over luftvegsprøver, Mikrobiologisk
avdeling, HUS. |
2020-2021 |
|
|
Inneliggjande pasientar |
Veke 21-38 |
|
Veke 21-37 |
|
Veke 21-36 |
|
Veke 21-35 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
145 |
<5 |
|
|
|
Bordetella parapertussis |
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
145 |
<5 |
|
|
|
Mycoplasma pneumoniae |
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
145 |
<5 |
|
|
|
Chlamydia pneumoniae |
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
145 |
<5 |
|
|
|
Influensavirus A |
408 |
<5 |
|
|
418 |
<5 |
|
|
419 |
<5 |
|
|
389 |
<5 |
|
|
|
Influensavirus B |
408 |
<5 |
|
|
418 |
<5 |
|
|
419 |
<5 |
|
|
389 |
<5 |
|
|
|
Parainfluensavirus 1 |
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
145 |
<5 |
|
|
|
Parainfluensavirus 2 |
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
145 |
<5 |
|
|
|
Parainfluensavirus 3 |
157 |
17 |
11 % |
|
150 |
12 |
8 % |
|
150 |
6 |
4 % |
|
145 |
7 |
5 % |
|
|
Respiratorisk syncytialt virus |
383 |
6 |
2 % |
|
258 |
<5 |
|
|
274 |
<5 |
|
|
247 |
<5 |
|
|
|
Humant metapneumovirus |
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
145 |
<5 |
|
|
|
Rhinovirus |
157 |
25 |
16 % |
|
150 |
27 |
18 % |
|
150 |
13 |
9 % |
|
145 |
22 |
15 % |
|
|
SARS-CoV-2 |
486 |
5 |
1 % |
|
494 |
<5 |
|
|
499 |
<5 |
|
|
498 |
6 |
1 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ambulante pasientar |
Veke 21-38 |
|
Veke 21-37 |
|
Veke 21-36 |
|
Veke 21-35 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
358 |
<5 |
|
|
|
Bordetella parapertussis |
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
358 |
<5 |
|
|
|
Mycoplasma pneumoniae |
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
358 |
<5 |
|
|
|
Chlamydia pneumoniae |
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
358 |
<5 |
|
|
|
Influensavirus A |
437 |
<5 |
|
|
390 |
<5 |
|
|
436 |
<5 |
|
|
373 |
<5 |
|
|
|
Influensavirus B |
437 |
<5 |
|
|
390 |
<5 |
|
|
436 |
<5 |
|
|
373 |
<5 |
|
|
|
Parainfluensavirus 1 |
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
358 |
<5 |
|
|
|
Parainfluensavirus 2 |
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
358 |
<5 |
|
|
|
Parainfluensavirus 3 |
425 |
100 |
24 % |
|
386 |
70 |
18 % |
|
402 |
61 |
15 % |
|
358 |
42 |
12 % |
|
|
Respiratorisk syncytialt virus |
435 |
15 |
3 % |
|
388 |
13 |
3 % |
|
416 |
17 |
4 % |
|
365 |
11 |
3 % |
|
|
Humant metapneumovirus |
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
358 |
<5 |
|
|
|
Rhinovirus |
425 |
108 |
25 % |
|
386 |
106 |
27 % |
|
402 |
117 |
29 % |
|
358 |
116 |
32 % |
|
|
SARS-CoV-2 |
11514 |
167 |
1 % |
|
14571 |
211 |
1 % |
|
20459 |
382 |
2 % |
|
26623 |
592 |
2 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inneliggjande pasientar omfatter fleire
sjukehus i vår region |
|
|
|
|
|
|
|
30.09.2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|